Search

Search Constraints

You searched for: Author/Creator Bronze-da-Rocha, Elsa

Search Results

11. P1531DIURETIC USE IN HEMODIALYSIS PATIENTS: BENEFIC ASSOCIATION WITH RESIDUAL RENAL FUNCTION AND ALL-CAUSE MORTALITY. (6th June 2020)

12. P1570INTERLEUKIN-6 (RS1800795) AND PENTRAXIN 3 (RS2305619) GENETIC POLYMORPHISMS AND THEIR RELATION WITH INFLAMMATION AND ALL-CAUSE MORTALITY IN ESRD PATIENTS ON DIALYSIS. (6th June 2020)

13. P1581IMPACT OF ACHIEVING LDL CHOLESTEROL LOWER THAN 100 MG/DL WITH STATINS, ON LIPID PROFILE AND INFLAMMATION IN END-STAGE RENAL DISEASE PATIENTS. (6th June 2020)

14. Potential Cardiovascular Risk Protection of Bilirubin in End-Stage Renal Disease Patients under Hemodialysis. (9th September 2014)

15. Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study. Issue 6 (24th November 2013)

16. SP261ATHEROGENIC PROPERTIES OF LDL PARTICLES IN ESRD PATIENTS ON HEMODIALYSIS. (18th May 2018)

17. SP261ATHEROGENIC PROPERTIES OF LDL PARTICLES IN ESRD PATIENTS ON HEMODIALYSIS. (18th May 2018)

19. SP342HEPCIDIN-25 AND TREATMENT WITH ERYTHROPOIESIS STIMULATING AGENTS ARE INDEPENDENTLY RELATED WITH ERYTHROPOIESIS IN CHRONIC HEMODIALYSIS PATIENTS. (18th May 2018)

20. SP342HEPCIDIN-25 AND TREATMENT WITH ERYTHROPOIESIS STIMULATING AGENTS ARE INDEPENDENTLY RELATED WITH ERYTHROPOIESIS IN CHRONIC HEMODIALYSIS PATIENTS. (18th May 2018)